Achaogen Plans for Near-Term Sale Using Structured Process Through C...

04/15/19

Achaogen Plans for Near-Term Sale Using Structured Process Through Chapter 11 of the US Bankruptcy Code  Nasdaq

SOUTH SAN FRANCISCO, Calif., April 15, 2019-- Achaogen, Inc., a biopharmaceutical company developing and commercializing innovative antibacterial.

[more]